Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed the HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T14:44:11.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Publications section updated to state that publications are provided by the entry author and are about the study results; PubMed auto-fill remains, and the revision tag was updated from v3.2.0 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-11-25T14:16:03.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed the banner notice about a lapse in government funding on the ClinicalTrials.gov page for ARCADIA (NCT03824691), which is an administrative detail rather than core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:25:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    No significant additions or deletions were observed on the ARCADIA study page. The published study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:07.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:10:31.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Page revision updated to v3.1.0 with new contact emails added; v3.0.2 removed. No clear changes to pricing or stock detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:37:31.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.